Biomarker Tests Market Research Report Information By Application (Cancer, Cardiovascular, Infectious Diseases, Central Nervous Systems, and Others), By End User (Pharma & Biotech Companies, Diagnostic Tools Companies, Healthcare It/ Big Data Companies, and Clinical Laboratories), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

1 Report Prologue

1.1 Introduction 10

1.2 FDA Regulations 11

2 Scope Of The Study

2.1 Introduction 13

2.2 Research Objective 13

2.3 Assumptions & Limitations 14

2.3.1 Assumptions 14

2.3.2 Limitations 14

2.4 Market Structure 14

3 Research Methodology

3.1 Primary Research 16

3.2 Secondary Research 16

4 Market Factor Analysis

4.1 Porters Five Forces 17

4.1.1 Bargaining Power Of Suppliers 18

4.1.2 Bargaining Power Of Buyer 18

4.1.3 Threat Of Substitutes 18

4.1.4 Threat Of New Entrants 19

4.1.5 Intensity Of Rivalry 19

4.2 Value Chain 19

4.2.1 Device Manufacturer & Drug Producers 20

4.2.2 Healthcare Providers 20

4.2.3 Healthcare ITs Or Big Data Companies 20

4.2.4 Regulators 20

4.2.5 Third Party Payers 20

4.2.6 Patients 20

5 Market Dynamics

5.1 Introduction 21

5.2 Drivers 21

5.2.1 Involvement Of Patients In Personal Healthcare 21

5.2.2 Demand For Biomarkers In Other Technologies Such As Next-Generation Sequencing Technologies And Ultra-High Throughput Sequencing. 21

5.2.3 Growing Prevalence Of Genetic Diseases 22

5.2.4 Growing Potential For Biomarkers In Targeted Therapies 22

5.3 Restrains 22

5.3.1 Lack Of Awareness About The Possible Applications Of Biomarkers 22

5.3.2 Regulatory Framework 22

5.3.3 Lack Of Research And Indications Creating Difficulties In The Application 23

5.4 Opportunities 24

5.4.1 Introduction Of Biomarkers In Developing Nations 24

6 Biomarker Test Market, By Applications

6.1 Cancer Application 26

6.2 Cardiovascular Application 26

6.3 Infectious Diseases Application 27

6.4 Central Nervous System Application 27

6.5 Others Applications 28

7 Biomarker Test Market, By End Users

7.1 Pharma & Biotech Companies 30

7.2 Diagnostic Tool Companies 30

7.3 Healthcare IT/Big Data Companies 31

7.4 Clinical Laboratories 31

8 Biomarker Test Market, By Regions

8.1 North America 33

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.1.1 US 35

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.1.2 Canada 36

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.2 Europe 37

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.2.1 Germany 39

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.2.2 France 40

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.2.3 UK 41

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.2.4 Italy 42

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.2.5 Spain 43

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.2.6 Rest Of Europe 44

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.3 Asia-Pacific 45

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.3.1 Japan 47

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.3.2 China 48

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.3.3 India 49

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.3.4 South Korea 50

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.3.5 Australia 51

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.3.6 Rest Of Asia-Pacific 52

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.4 Middle East & Africa 53

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.4.1 UAE 55

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.4.2 Saudi Arabia 56

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.4.3 Egypt 57

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

8.4.4 Rest Of Middle & Africa 58

Biomarker Test Market, By Applications

Biomarker Test Market, By End Users

Biomarker Test Market, By Regions

9 Competitive Landscape

10 Company Profiles

10.1 F. Hoffmann-La Roche AG 60

10.1.1 Overview 60

10.1.2 Product/Business Segment Overview 60

10.1.3 Financial Updates 61

10.1.4 Key Developments 61

10.1.5 SWOT Analysis 62

10.2 Novartis AG 63

10.2.1 Overview 63

10.2.2 Product/Business Segment Overview 63

10.2.3 Financial Updates 64

10.2.4 Key Developments 65

10.2.5 SWOT Analysis 65

10.3 Pfizer Inc. 66

10.3.1 Overview 66

10.3.2 Product/Business Segment Overview 66

10.3.3 Financial Updates 66

10.3.4 Key Developments 67

10.3.5 SWOT Analysis 68

10.4 GlaxoSmithKline Plc. 69

10.4.1 Company Overview 69

10.4.2 Product Overview 69

10.4.3 Financial Overview 69

10.4.4 Key Developments 70

10.4.5 SWOT Analysis 71

10.5 GE Healthcare 72

10.5.1 Company Overview 72

10.5.2 Product/Business Segment Overview 72

10.5.3 Financial Overview 72

10.5.4 Key Developments 73

10.5.5 SWOT Analysis 74

10.6 Medtronics 75

10.6.1 Company Overview 75

10.6.2 Product/Business Segment Overview 75

10.6.3 Financial Overview 75

10.6.4 Key Developments 76

10.7 Quest Diagnostics 78

10.7.1 Company Overview 78

10.7.2 Product Overview 78

10.7.3 Financial Overview 78

10.7.4 Key Developments 79

11 List Of Tables

TABLE 1 CANCER BIOMARKERS FOR WHICH TESTING IS MANDATED BY THE FDA PRIOR TO USE OF THE DRUG 11

TABLE 2 GLOBAL BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 25

TABLE 3 GLOBAL BIOMARKER TEST MARKET, BY CANCER APPLICATION (USD MILLION) (2023-2030) 26

TABLE 4 GLOBAL BIOMARKER TEST MARKET, BY CARDIOVASCULAR APPLICATION (USD MILLION) (2023-2030) 26

TABLE 5 GLOBAL BIOMARKER TEST MARKET, BY INFECTIOUS DISEASES APPLICATION (USD MILLION) (2023-2030) 27

TABLE 6 GLOBAL BIOMARKER TEST MARKET, BY CENTRAL NERVOUS SYSTEM APPLICATION (USD MILLION)

(2023-2030) 27

TABLE 7 GLOBAL BIOMARKER TEST MARKET, BY OTHERS APPLICATION (USD MILLION) (2023-2030) 28

TABLE 8 GLOBAL BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 29

TABLE 9 GLOBAL BIOMARKER TEST MARKET, BY PHARMA & BIOTECH COMPANIES (USD MILLION) (2023-2030) 30

TABLE 10 GLOBAL BIOMARKER TEST MARKET, BY DIAGNOSTIC TOOL COMPANIES END USER (USD MILLION) (2023-2030) 30

TABLE 11 GLOBAL BIOMARKER TEST MARKET, BY HEALTHCARE IT/BIG DATA COMPANIES END USER (USD MILLION) (2023-2030) 31

TABLE 12 GLOBAL BIOMARKER TEST MARKET, BY CLINICAL LABORATORIES END USER (USD MILLION) (2023-2030) 31

TABLE 13 GLOBAL BIOMARKER TESTS MARKET, BY REGION (USD MILLION) (2023-2030) 32

TABLE 14 NORTH AMERICA BIOMARKER TESTS MARKET, BY COUNTRY (USD MILLION) (2023-2030) 33

TABLE 15 NORTH AMERICA BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 34

TABLE 16 NORTH AMERICA BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 34

TABLE 17 US BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 35

TABLE 18 US BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 35

TABLE 19 CANADA BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 36

TABLE 20 CANADA BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 36

TABLE 21 EUROPE BIOMARKER TESTS MARKET, BY COUNTRY (USD MILLION) (2023-2030) 37

TABLE 22 EUROPE BIOMARKER TESTS MARKET, BY APPLICATION BY APPLICATION (USD MILLION) (2023-2030) 38

TABLE 23 EUROPE BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 38

TABLE 24 GERMANY BIOMARKER TESTS MARKET, BY APPLICATION BY APPLICATION (USD MILLION) (2023-2030) 39

TABLE 25 GERMANY BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 39

TABLE 26 FRANCE BIOMARKER TESTS MARKET, BY APPLICATION BY APPLICATION (USD MILLION) (2023-2030) 40

TABLE 27 FRANCE BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 40

TABLE 28 UK BIOMARKER TESTS MARKET, BY APPLICATION BY APPLICATION (USD MILLION) (2023-2030) 41

TABLE 29 UK BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 41

TABLE 30 ITALY BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 42

TABLE 31 ITALY BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 42

TABLE 32 SPAIN BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 43

TABLE 33 SPAIN BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 43

TABLE 34 REST OF EUROPE BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 44

TABLE 35 REST OF EUROPE BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 44

TABLE 36 ASIA-PACIFIC BIOMARKER TESTS MARKET BY, COUNTRY (USD MILLION) (2023-2030) 45

TABLE 37 ASIA-PACIFIC BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 46

TABLE 38 ASIA-PACIFIC BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 46

TABLE 39 JAPAN BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 47

TABLE 40 JAPAN BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 47

TABLE 41 CHINA BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 48

TABLE 42 CHINA BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 48

TABLE 43 INDIA BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 49

TABLE 44 INDIA BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 49

TABLE 45 SOUTH KOREA BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 50

TABLE 46 SOUTH KOREA BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 50

TABLE 47 AUSTRALIA BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 51

TABLE 48 AUSTRALIA BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 51

TABLE 49 REST OF ASIA-PACIFIC BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 52

TABLE 50 REST OF ASIA-PACIFIC BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 52

TABLE 51 MIDDLE EAST & AFRICA BIOMARKER TESTS MARKET BY, COUNTRY (USD MILLION) (2023-2030) 53

TABLE 52 MIDDLE EAST & AFRICA BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 54

TABLE 53 MIDDLE EAST & AFRICA BIOMARKER TESTS MARKET, BY END USER (USD MILLION) (2023-2030) 54

TABLE 54 UAE BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 55

TABLE 55 UAE BIOMARKER TESTS MARKET, BY END USER (USD MILLION) (2023-2030) 55

TABLE 56 SAUDI ARABIA BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 56

TABLE 57 SAUDI ARABIA BIOMARKER TESTS MARKET, BY END USER (USD MILLION) (2023-2030) 56

TABLE 58 EGYPT BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 57

TABLE 59 EGYPT BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 57

TABLE 60 REST OF MIDDLE & AFRICA BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 58

TABLE 61 REST OF MIDDLE & AFRICA BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 58

TABLE 62 GE HEALTHCARE: KEY DEVELOPMENT 73

TABLE 63 MEDTRONICS: KEY DEVELOPMENT 76

12 List Of Figures

FIGURE 1 REGULATORY PATHWAY OPTION FOR DIAGNOSTICS 12

FIGURE 2 RESEARCH PROCESS 15

FIGURE 3 GLOBAL BIOMARKER TESTS MARKET, BY APPLICATION (USD MILLION) (2023-2030) 25

FIGURE 4 GLOBAL BIOMARKER TESTS MARKET, BY END USERS (USD MILLION) (2023-2030) 29

FIGURE 5 GLOBAL BIOMARKER TESTS MARKET, BY REGION (USD MILLION) (2023-2030) 32

FIGURE 6 NORTH AMERICA BIOMARKER TESTS MARKET, BY COUNTRY MARKET SHARE 2018 (%) 33

FIGURE 7 EUROPE BIOMARKER TESTS MARKET, BY COUNTRY MARKET SHARE 2018 (%) 37

FIGURE 8 ASIA-PACIFIC BIOMARKER TESTS MARKET BY, COUNTRY MARKET SHARE 2018 (%) 45

FIGURE 9 MIDDLE EAST & AFRICA BIOMARKER TESTS MARKET BY, COUNTRY MARKET SHARE 2018 (%) 53

FIGURE 10 GLOBAL BIOMARKER TEST COMPETITIVE ANALYSIS (%) 59

FIGURE 11 F. HOFFMANN-LA ROCHE AG: FINANCIAL REVENUE 61

FIGURE 12 F. HOFFMANN-LA ROCHE AG: SEGMENTAL REVENUE 61

FIGURE 13 NOVARTIS FINANCIAL DATA: REVENUE AND R&D 64

FIGURE 14 NOVARTIS FINANCIAL DATA: SEGMENTAL REVENUE 64

FIGURE 15 NOVARTIS FINANCIAL DATA: GEOGRAPHICAL REVENUE 64

FIGURE 16 PFIZER FINANCIAL DATA: REVENUE AND R&D 66

FIGURE 17 PFIZER FINANCIAL DATA SEGMENTAL REVENUE 67

FIGURE 18 PFIZER FINANCIAL DATA GEOGRAPHICAL REVENUE 67

FIGURE 19 GLOAXOSMITHKLINE: RECENT FINANCIAL 69

FIGURE 20 GLAXOSMITHKLINE: OPERATING SEGMENTS 70

FIGURE 21 GLAXOSMITHKLINE: GEOGRAPHICAL MIX 70

FIGURE 22 GE HEALTHCARE: RECENT FINANCIAL 72

FIGURE 23 GE HEALTHCARE: OPERATING SEGMENTS 73

FIGURE 24 GE HEALTHCARE: GEOGRAPHICAL MIX 73

FIGURE 25 MEDTRONICS: RECENT FINANCIAL 75

FIGURE 26 MEDTRONICS: OPERATING SEGMENTS 76

FIGURE 27 MEDTRONICS: GEOGRAPHICAL MIX 76

FIGURE 28 QUEST DIAGNOSTICS: OPERATING INCOME 78

FIGURE 29 QUEST DIAGNOSTICS: SEGMENTAL REVENUE 79